NM_000391.4:c.225A>G
Variant summary
The NM_000391.4(TPP1):c.225A>G (p.Gln75Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0000105 (AC=17) in the gnomAD database across 1,613,724 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000236. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV002768068: "This variant has strong functional evidence supporting abnormal protein function. Individuals either compound heterozygous or homozygous for this variant, have been consistently demonstrated to have reduced Tpp1 enzyme activity, considered to be the gold standard of diagnosing individuals with neuronal ceroid lipofuscinosis 2 (PMID:10330339, PMID:32329550, PMID:23418007, Nunes, A. et al. (2020))."".
Frequency
Consequence
NM_000391.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosis 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Natera, Myriad Women's Health, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive spinocerebellar ataxia 7Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 11 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV002768068: "This variant has strong functional evidence supporting abnormal protein function. Individuals either compound heterozygous or homozygous for this variant, have been consistently demonstrated to have reduced Tpp1 enzyme activity, considered to be the gold standard of diagnosing individuals with neuronal ceroid lipofuscinosis 2 (PMID: 10330339, PMID: 32329550, PMID: 23418007, Nunes, A. et al. (2020))." | ||
| PM2Absent/extremely low in population databases | Rare in gnomAD for AR/unknown gene (popmax AF below threshold) — PM2 Supporting; GnomAD popmax AF = 0.000236 — borderline rare for AR gene (base 0.001, raised to 0.00126 by highest known P/LP ClinVar AF 0.00126) — PM2 supporting. | ||
| PP3Computational evidence supports damaging effect | Splicing predictors (SpliceAI/dbscSNV) support splicing impact — moderate computational evidence (PP3); Splicing verdict: pathogenic (Moderate).; Germline computational verdict: not pathogenic. | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000391.4. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TPP1 | TSL:1MANE Select | c.225A>G p.Gln75Gln | synonymous | Exon 3 of 13 | Prot: ENSP00000299427.6 UniProt: | |
TPP1 | TSL:1 | c.-505A>G | 5_prime_UTR | Exon 2 of 12 | Prot: ENSP00000437066.1 UniProt: | |
TPP1 | TSL:1 | c.*412A>G | 3_prime_UTR | Exon 2 of 2 | Prot: ENSP00000435001.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000329 | AC:5 | Hom:0 | AN:152124 | Cov:32 |
GnomAD2 exomes | AF: 0.0000319 | AC:8 | AN:251124 | ||
GnomAD4 exome | AF: 0.00000821 | AC:12 | Hom:0 | AN:1461600 | Cov:31 |
GnomAD4 genome | AF: 0.0000329 | AC:5 | Hom:0 | AN:152124 | Cov:32 |
TOPMed (Bravo) | AF: 0.0000604 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.000165 | AC:7 | Hom:0 | AN:42482 | |
Local & regional cohorts 1 source | |||||
ESP6500 (Exome Variant Server) | AF: 0.0000770 | AC:1 | AN:12994 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
Epi25 | 0.0000238 | 1 | 41958 | 0.00 | 0 | 66888 |
SCHEMA | 0.00000884 | 1 | 113126 | 0.00000525 | 1 | 190618 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 24 | |
BayesDel_noAF | Benign | -0.90 | |
CADD | Benign | 19 | |
DANN | Benign | 0.70 | |
GPN-Star LLR | N/A | -3.5 | |
GPN-Star score | N/A | 3.5 | |
Mutation Taster | N/A | 99/1 | disease causing (ClinVar) |
PhyloP100 | Benign | -2.1 | |
PromoterAI | N/A | 0.0044 | Neutral |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
DS_DG_spliceai | Pathogenic | 0.97 | Position offset: 1 |
DS_DL_spliceai | Pathogenic | 0.60 | Position offset: -4 |
Pangolin (max) | Pathogenic | 0.73 | |
Pangolin gain | Pathogenic | 0.73 | Position offset: 1 |
Pangolin loss | Uncertain | 0.35 | Position offset: -4 |
SpliceAI score (max) | Pathogenic | 0.97 | Details are displayed if max score is > 0.2 |
Splicevardb | N/A | 3.0 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.